Professional Documents
Culture Documents
NOTES
TRYPANOSOMA
Transmission TREATMENT
▪ Through vectors
▪ Incubation period: 1–2 weeks ▪ See individual pathogens
TRYPANOSOMA BRUCEI
osms.it/trypanosoma-brucei
susceptibility (mechanism unknown)
PATHOLOGY & CAUSES
Morphologic forms (life-cycle)
▪ Protozoan, extracellular parasite → African ▪ Epimastigote → procyclic trypomastigote
trypanosomiasis (in tsetse fly midgut) → metacyclic
▪ AKA “sleeping sickness” trypomastigote (infectious form)
▫ Neurologic alterations during
Subspecies
meningoencephalitis stage (e.g.
somnolence) ▪ Trypanosoma brucei rhodesiense (acute,
more severe disease course)
Virulence factors ▪ Trypanosoma brucei gambiense
▪ Antigenic variation (progressive, milder disease course)
▫ Changes variant surface glycoprotein
Reservoirs
(VSG) → immune response evasion
▪ Domestic animals, lions, hyenas, antelopes
▪ ↑ interferon gamma → ↑ host T. brucei
578 OSMOSIS.ORG
Chapter 104 Trypanosoma brucei
Vector ▪ Lymphadenopathy
▪ Male/female Glossina flies, AKA tsetse flies ▫ Winterbottom’s sign: enlarged mobile,
▫ Ideal conditions: warm, humid soft posterior cervical triangle lymph
climate (e.g. near river/lake); altitude < nodes
1800m/5905ft ▪ Hepatosplenomegaly
▪ Dyspnea
Transmission
▪ Chest pain
▪ Saliva inoculation via fly bite; vertical/
▪ Altered thyroid function
parenteral transmission very rare
▪ Impotence (biologically-male), amenorrhea
▪ Endemic regions: sub-Saharan Africa;
(biologically-female)
Democratic Republic of Congo (most cases)
▪ Pain, Kerandel sign (deep hyperesthesia)
Pathogenesis
Meningoencephalitis stage
▪ Glossina bite → subcutaneous metacyclic
trypomastigote inoculation → lymph ▪ AKA “Sleeping sickness”
vessels → bloodstream → ↑ tumor necrosis ▪ Cachexia
factor (TNF) alpha, interleukin 6 (IL-6), ▪ Sleep disturbances (e.g. diurnal
nitric oxide → ↑ capillary permeability → somnolence, nocturnal insomnia)
vasculitis → organ invasion, e.g. central ▪ Headaches
nervous system (CNS) ▪ Altered state of consciousness
Disease stages ▪ ↓ cognitive function
▪ Hemolymphatic (early) stage ▪ Personality, behavioral change
▪ Meningoencephalitis (late) stage ▪ Muscle spasms, ataxia, tremor, flaccid
▪ Symptom severity related to number of paralysis, choreiform movements
organisms in affected tissue (e.g. blood, ▪ Psychiatric manifestations (e.g. psychosis)
CNS)
DIAGNOSIS
RISK FACTORS
▪ Recent endemic area travel DIAGNOSTIC IMAGING
▪ Dense vegetation near human settlement
MRI
▪ Cerebral
COMPLICATIONS
▫ May show multifocal white matter
▪ Meningitis
hyperintensity (indicates late-stage
▪ Myocarditis, heart failure disease)
▪ Aspiration → bacterial pneumonia;
associated with altered state of
consciousness (meningoencephalitis stage) LAB RESULTS
Serologic testings
SIGNS & SYMPTOMS ▪ Card agglutination test for trypanosomiasis
(CATT)
Hemolymphatic stage ▫ Blood + drop of reagent with
trypanosomal antigen
▪ Systemic symptoms
▪ Immunofluorescence
▫ Intermittent fever, headache, malaise,
weakness, pruritus, rash ▪ Enzyme immunoassays
▪ Trypanosomal chancre Cerebrospinal fluid (CSF) examination
▫ Rubbery, painful, erythematous, well- ▪ Disease staging essential
circumscribed lesion at fly bite site
▪ ↑ leukocytes
approx. one week post-inoculation
▪ ↑ proteins
▪ IgM/Trypanosoma presence
OSMOSIS.ORG 579
▪ Morula/Mott cells (pathognomonic) OTHER DIAGNOSTICS
▫ IgM-filled plasma cells
Electroencephalogram (EEG)
Direct microscopy ▪ Late stage: abnormal, slow delta waves
▪ Organism observation in lymph node
aspiration, bone marrow, CSF, blood (thin/
thick Giemsa-stained smears)
Laboratory findings
▪ Hemolytic anemia; leukocytosis;
TREATMENT
thrombocytopenia; ↑
erythrocyte sedimentation rate;
MEDICATIONS
hypergammaglobulinemia; ▪ Antiprotozoal medication
hypoalbuminemia, hypocomplementemia; ▫ Hemolymphatic stage: pentamidine,
↑ C-reactive protein; coagulation suramin
abnormalities ▫ Meningoencephalitis stage: eflornithine,
eflornithine + nifurtimox, melarsoprol
Histological observation
▪ Meningoencephalitis stage (CSF sample)
OTHER INTERVENTIONS
▫ Morula/Mott cells in white
matter (pathognomonic), edema, ▪ Prevention
microhemorrhages, perivascular ▫ Vector control, surveillance
proliferation ▫ Protective clothing
TRYPANOSOMA CRUZI
osms.it/trypanosoma-cruzi
Transmission
PATHOLOGY & CAUSES ▪ Triatomine bite → fecal wound
contamination
▪ Protozoan, intracellular parasite
▪ Contaminated food/water ingestion
▫ Causes American trypanosomiasis, AKA (infection through mucous membranes)
Chagas disease
▪ Parenteral (e.g. blood transfusion, sharing
▪ Morphologic forms (life cycle) syringes)
▫ Amastigote (intracellular, no flagellum) ▪ Vertical (mother → fetus)
→ epimastigote (in triatomine midgut)
→ trypomastigote (infectious form) Endemic regions
▪ Reservoirs ▪ Rural areas of southern U.S., Latin America
▫ Opossums, armadillos, canines
Pathogenesis
▪ Vectors
▪ T. cruzi trypomastigote inoculation →
▫ Triatomine bugs (“kissing bugs”)
bloodstream → organ invasion (heart,
▫ Common species: Rhodnius prolixus, enteric nervous system) → interstitial
Triatoma dimidiata, Triatoma infestans inflammation → tissue destruction →
▫ Characteristics: size (2–3cm/0.79– fibrosis
1.18in); obligated hematogenous; feeds
at night; lives in dark, warm sites (e.g. Disease stages
closets, thatched roofs) ▪ Acute phase: 8–12 weeks
▪ Indeterminate phase: decades
580 OSMOSIS.ORG
Chapter 104 Trypanosoma brucei
Indeterminate phase
▪ Asymptomatic
Chronic phase
▪ Cardiac manifestations: dyspnea, fatigue,
palpitation, chest pain, edema, mitral/
tricuspid regurgitation murmur, splitting of
S2
▪ Gastrointestinal manifestations: megacolon
(constipation, bloating, abdominal pain);
megaesophagus (dysphagia, regurgitation)
Congenital disease
▪ Systemic: low birthweight, anasarca, fever
▪ Petechiae
▪ Hepatosplenomegaly
▪ Neurologic abnormalities (e.g. hypotonia,
tremor)
DIAGNOSIS
DIAGNOSTIC IMAGING
▪ Further studies: stage, clinical syndrome
dependent
Barium studies
▪ Megacolon, megaesophagus
LAB RESULTS
▪ Polymerase chain reaction (PCR)
OSMOSIS.ORG 581
▪ Blood culture
Direct microscopy
▪ Organism observation in thin/thick blood
smears; for acute phase disease (high
parasitemia)
Serologic testing
▪ E.g. enzyme-linked immunosorbent assay
(ELISA), immunofluorescence
Xenodiagnosis
▪ Feed laboratory triatomes with person’s Figure 104.2 Trypanosoma species seen on
blood → examine feces weeks later a peripheral blood smear from an individual
with Chagas disease.
Cardiac tissue microscopy
▪ Acute disease: intracellular pseudocysts
(amastigotes inside myocardiocytes),
interstitial inflammation
▪ Chronic disease: mural thrombi, interstitial
fibrosis, myocardiocyte necrosis
OTHER DIAGNOSTICS
ECG
▪ Arrhythmia evidence: bundle branch/AV
block
TREATMENT
MEDICATIONS
▪ Antitrypanosomal treatment
▪ Advanced cardiac disease: cardiac arrest
prevention, ventricular fibrillation through
antiarrhythmic medication
OTHER INTERVENTIONS
Prevention
▪ Vector control, treat parasitemia before
conception
582 OSMOSIS.ORG